Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 5
Submit an article Journal homepage
328
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Pilot trial of yttrium-90 ibritumomab tiuxetan consolidation following rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone chemotherapy in patients with limited-stage, bulky diffuse large B-cell lymphoma

Deok-Hwan YangChonnam National University Hwasun Hospital, Jeollanam-do, Korea
,
Won Seog KimSungkyunkwan University School of Medicine, Seoul, Korea
,
Seok Jin KimSungkyunkwan University School of Medicine, Seoul, Korea
,
Jin Seok KimYonsei University College of Medicine, Seoul, Korea
,
Jae-Yong KwakChonbuk National University Medical School, Jeollabukdo, Korea
,
Joo Seop ChungPusan National University Hospital, Busan, Korea
,
Sung Yong OhDong-A University College of Medicine, Busan, Korea
,
Cheolwon SuhUniversity of Ulsan College of Medicine, Seoul, Korea
&
Je-Jung LeeChonnam National University Hwasun Hospital, Jeollanam-do, KoreaCorrespondence[email protected]
 show all
Pages 807-811 | Received 27 Jul 2011, Accepted 21 Oct 2011, Published online: 07 Dec 2011

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jose C Villasboas & Stephen M Ansell. (2015) Therapeutic targets and investigated strategies for treating B-cell non-Hodgkin lymphoma. Expert Opinion on Orphan Drugs 3:8, pages 921-932.
Read now
Matthew S McKinney & Anne W Beaven. (2014) Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma. Blood and Lymphatic Cancer: Targets and Therapy 4, pages 45-59.
Read now

Articles from other publishers (8)

Esha Sharda, Raahil S. Patel, Luis Miguel Juárez-Salcedo, Samir Dalia, Catherine H. Hanna, Hanan Gruhonjic, Bharat S. Ponnaganti & Rahul Mhaskar. (2021) Adverse events of radioimmunotherapy for non-Hodgkin lymphoma: A systematic review and meta-analysis. Leukemia Research 108, pages 106615.
Crossref
Kwai Han Yoo, Hyewon Lee & Cheolwon Suh. (2018) Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial. International Journal of Hematology 107:4, pages 395-404.
Crossref
Ilseung Choi & Naokuni Uike. 2018. Resistance to Ibritumomab in Lymphoma. Resistance to Ibritumomab in Lymphoma 1 8 .
Jew Win Kuan, Chiong Soon Law, Xiang Qi Wong, Ching Tiong Ko, Zool Hilmi Awang, Lee Ping Chew & Kian Meng Chang. (2016) A pioneer experience in Malaysia on In-house Radio-labelling of 131I-rituximab in the treatment of Non-Hodgkin's Lymphoma and a case report of high dose 131I-rituximab-BEAM conditioning autologous transplant. Applied Radiation and Isotopes 116, pages 13-21.
Crossref
Dong-Yeop Shin, Byung Hyun Byun, Kyeong Min Kim, Joo Hyun Kang, Ilhan Lim, Byung Il Kim, Seung-Sook Lee, Chang Woon Choi, Hye Jin Kang & Sang Moo Lim. (2016) Radioimmunotherapy with 131I-rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma. Cancer Chemotherapy and Pharmacology 78:4, pages 825-831.
Crossref
Naokuni Uike, Ilseung Choi, Mariko Tsuda, Shojirou Haji, Kousuke Toyoda, Youko Suehiro, Yasunobu Abe, Toshinobu Hayashi, Hirofumi Sawamoto, Koichiro Kaneko, Mototsugu Shimokawa & Makoto Nakagawa. (2014) Factors associated with effects of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory low-grade B cell non-Hodgkin lymphoma: single-institution experience with 94 Japanese patients in rituximab era. International Journal of Hematology 100:4, pages 386-392.
Crossref
Karin Hohloch, H. K. Lankeit, P. L. Zinzani, C. W. Scholz, M. Lorsbach, C. Windemuth-Kieselbach & L. Trümper. (2014) Radioimmunotherapy for first-line and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: an analysis of 215 patients registered in the international RIT-Network. European Journal of Nuclear Medicine and Molecular Imaging 41:8, pages 1585-1592.
Crossref
Cheolwon SuhWon Seog KimJin Seok KimByeong-Bae Park. (2013) Review of the clinical research conducted by the Consortium for Improving Survival of Lymphoma of the Korean Society of Hematology Lymphoma Working Party. Blood Research 48:3, pages 171.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.